Xentria, Inc.
Clinical trials sponsored by Xentria, Inc., explained in plain language.
-
New insulin shows promise in healthy volunteers
Knowledge-focused CompletedThis study tested a new insulin (NKF-INS(A)) to see if it works the same as two already-approved insulins (US-NovoLog and EU-NovoRapid). Fifty-four healthy men received a single dose of each insulin in a random order, and researchers measured how the body absorbed and responded t…
Phase: PHASE1 • Sponsor: Xentria, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 12:12 UTC
-
New insulin put to the test against market leaders
Knowledge-focused CompletedThis study checked if a new insulin (NKF-INS(L)) works the same way in the body as two already-approved insulins (US-Humalog and EU-Humalog). Fifty-four healthy men received a single dose of each insulin in a random order, and their blood sugar and insulin levels were measured. T…
Phase: PHASE1 • Sponsor: Xentria, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 12:08 UTC